Literature DB >> 19623881

Guidelines for breast cancer screening in Lebanon Public Health Communication.

Salim M Adib1, Nagi S El Saghir, Walid Ammar.   

Abstract

The accumulation of national epidemiological data since the late 1990s has led to the adoption of evidence-based guidelines for breast cancer screening in Lebanon (2006). Almost 50% of breast cancer patients in Lebanon are below the age of 50 years and the age-adjusted incidence rate is estimated at 69 new cases per 100,000 per year (2004). This official notification calls for breast self-examination (BSE) every month starting age 20, and a clinical breast examination (CBE) performed by a physician every three years between the ages of 20 and 40 years. Starting age 40, and for as long as a woman is in good health, an annual CBE and mammography are recommended. Women with known genetic family history of breast cancer should start screening 10 years earlier than the first young patient in the family, or earlier depending on medical advice. The Breast Cancer National Task Force (BCNTF) recommends certification of mammography centers and continued training of personnel to assure high quality mammograms, and to minimize unnecessary investigations and surgeries.It recommends that a national program should record call-backs of women for annual screening and follow-up data on abnormal mammograms. BCNTF encourages the adoption of these guidelines and monitoring of their results, as well as follow-up of breast cancer epidemiology and registry in Lebanon, and scientific progress in early breast cancer detection to determine needs for modifications in the future.

Entities:  

Mesh:

Year:  2009        PMID: 19623881

Source DB:  PubMed          Journal:  J Med Liban        ISSN: 0023-9852


  11 in total

Review 1.  Preventing breast cancer in LMICs via screening and/or early detection: The real and the surreal.

Authors:  Subhojit Dey
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  Breast cancer in low- and middle-income countries: an emerging and challenging epidemic.

Authors:  Arafat Tfayli; Sally Temraz; Rachel Abou Mrad; Ali Shamseddine
Journal:  J Oncol       Date:  2010-12-15       Impact factor: 4.375

3.  Outcome of Breast Cancer Patients Treated outside of Clinical Trials.

Authors:  Nagi S El Saghir; Hussein A Assi; Sara M Jaber; Katia E Khoury; Zahi Nachef; Hana F Mikdashi; Nadine S El-Asmar; Toufic A Eid
Journal:  J Cancer       Date:  2014-06-03       Impact factor: 4.207

4.  Patterns and determinants of mammography screening in Lebanese women.

Authors:  Nadia Elias; Ibrahim R Bou-Orm; Salim M Adib
Journal:  Prev Med Rep       Date:  2016-12-23

5.  Sociological Transition and Breast Cancer in the Arab World: the Experience of Lebanon

Authors:  Najla A Lakkis; Salim M Adib; Ghassan Hamadeh; Rana El Jarrah; Mona H Osman
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01

6.  Psychosocial consequences of false-positive results in screening mammography.

Authors:  Zeina El Hachem; Marouan Zoghbi; Souheil Hallit
Journal:  J Family Med Prim Care       Date:  2019-02

7.  Primary care and pulmonary physicians' knowledge and practice concerning screening for lung cancer in Lebanon, a middle-income country.

Authors:  Imad Bou Akl; Nathalie K Zgheib; Maroun Matar; Deborah Mukherji; Marco Bardus; Rihab Nasr
Journal:  Cancer Med       Date:  2021-03-20       Impact factor: 4.452

8.  Trends in Breast Cancer Staging at Diagnosis Associated with Screening Campaigns in Lebanon.

Authors:  Christiane J El Khoury; Salim M Adib; Monique Chaaya; Khalil El Asmar; Maya Charafeddine; Nagi S El-Saghir
Journal:  Womens Health Rep (New Rochelle)       Date:  2020-11-26

9.  Knowledge, Attitudes and Practices Regarding Breast Cancer amongst Lebanese Females in Beirut

Authors:  Margueritta El Asmar; Amer Bechnak; Johny Fares; Dana Al Oweini; Ahmad Alrazim; Adnan El Achkar; Hani Tamim
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27

10.  Prevalence and pattern of comorbidities in chronic rheumatic and musculoskeletal diseases: the COMORD study.

Authors:  Nelly Ziade; Bernard El Khoury; Marouan Zoghbi; Georges Merheb; Ghada Abi Karam; Kamel Mroue'; Jamil Messaykeh
Journal:  Sci Rep       Date:  2020-05-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.